The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients

Clicks: 793
ID: 115975
2000
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #1 of 24 articles by views in journal of clinical oncology : official journal of the american society of clinical oncology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The risk index accurately identifies patients at low risk for complications and may be used to select patients for testing therapeutic strategies that may be more convenient or cost-effective.
Reference Key
j2000journalthe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Klastersky J;Paesmans M;Rubenstein EB;Boyer M;Elting L;Feld R;Gallagher J;Herrstedt J;Rapoport B;Rolston K;Talcott J;;
Journal journal of clinical oncology : official journal of the american society of clinical oncology
Year 2000
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10944139
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE Health Care humans pubmed abstract nih national institutes of health national library of medicine models prognosis reproducibility of results female male middle aged Prospective Studies Multicenter Study sensitivity and specificity anti-bacterial agents / therapeutic use Severity of Illness Index* outcome assessment neutropenia / chemically induced statistical* fever / drug therapy patient selection neutropenia / drug therapy fever / complications neutropenia / complications fever / diagnosis* antineoplastic agents / adverse effects* pmid:10944139 doi:10.1200/jco.2000.18.16.3038 j klastersky m paesmans j talcott fever / chemically induced neutropenia / diagnosis* risk assessment / methods

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.